Abbott (ABT) Reports In-Line Q4 Results, Offers Q1 and FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Abbott Reports Fourth-Quarter 2019 Results; Announces Strong Forecast for 2020
January 22, 2020 7:30 AM ESTABBOTT PARK, Ill., Jan. 22, 2020 /PRNewswire/ --Â Abbott (NYSE: ABT)Â today announced financial results for the fourth quarter and full year ended Dec. 31, 2019.
Fourth-quarter worldwide sales of $8.3 billion increased 7.1 percent on a reported basis and 8.5 percent on an organic* basis. Reported diluted EPS from continuing operations under GAAP was $0.59 in the fourth quarter. Adjusted diluted EPS from continuing operations, which excludes specified items, was $0.95, an increase of 17.3 percent versus prior year1. Abbott issues full-year 2020 guidance for organic sales growth of 7.0 to 8.0 percent2, which excludes the... More
